K
Kyungdong Pharm
KOSDAQ:011040
Kyungdong Pharm
KOSDAQ:011040
Price:
5 880
KRW
3.16%
Market Closed
Market Cap:
₩158.8B
Relative Value
The Relative Value of one Kyungdong Pharm stock under the Base Case scenario is hidden KRW. Compared to the current market price of 5 880 KRW, Kyungdong Pharm is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Kyungdong Pharm Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Kyungdong Pharm Competitors
Kyungdong Pharm Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Kyungdong Pharm
KOSDAQ:011040
|
158.5B KRW | 0.8 | 19.1 | 14.4 | 22.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD | 14.8 | 46.8 | 31.5 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD | 6.3 | 22.2 | 15.4 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.4B GBP | 5.5 | 31.7 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.5B CHF | 5.5 | 22.3 | 13.7 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD | 4.7 | 16.6 | 10.4 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.3 | 9.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR | 2.8 | 15.8 | 8 | 11.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
